Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥1.31T | ¥1.16T | ¥1.08T | ¥1.05T | ¥951.59B | ¥745.80B | ¥576.89B | ¥462.02B | ¥362.33B | ¥258.29B | ¥181.04B | ¥115.00B | ¥69.34B | ¥41.38B |
| Research & development | ¥22.23B | ¥17.03B | ¥16.39B | ¥16.89B | ¥16.33B | ¥16.15B | ¥14.62B | ¥12.14B | ¥6.65B | — | — | — | — | — |
| Operating income | ¥2.77B | ¥38.74B | ¥26.02B | ¥19.72B | ¥4.14B | ¥12.34B | ¥8.99B | −¥2.62B | −¥835.5M | −¥1.25B | −¥5.36B | −¥5.80B | −¥578.8M | −¥1.95B |
| EBITDAderived | ¥12.52B | ¥47.64B | ¥34.32B | ¥26.96B | ¥10.37B | ¥18.41B | ¥14.82B | ¥2.94B | ¥3.36B | ¥2.17B | −¥2.85B | −¥4.15B | −¥285.7M | −¥1.77B |
| Net income | ¥23.14B | ¥44.66B | ¥23.26B | ¥9.69B | −¥4.47B | ¥49.34B | ¥11.89B | −¥2.80B | −¥11.7M | −¥3.81B | −¥9.11B | −¥5.00B | −¥49.9M | −¥1.73B |
| Basic EPSper diluted share | CN¥6.89 | CN¥13.83 | CN¥7.69 | CN¥3.32 | -CN¥1.15 | CN¥16.35 | CN¥4.18 | -CN¥0.87 | -CN¥0.05 | -CN¥1.36 | -CN¥3.33 | -CN¥5.35 | -CN¥1.47 | -CN¥2.18 |
| Diluted EPSper diluted share | CN¥6.45 | CN¥13.43 | CN¥7.61 | CN¥3.21 | -CN¥1.15 | CN¥15.84 | CN¥4.11 | -CN¥0.87 | -CN¥0.05 | -CN¥1.36 | -CN¥3.33 | -CN¥5.35 | -CN¥1.47 | -CN¥2.18 |